levocabastine (Q2240116)

(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid

LEVOCABASTINE (English)

3 October 2016

2 references

inferred from InChIKey

based on heuristic

inferred from InChI

1 reference

based on heuristic

inferred from InChI

chemical formula

C₂₆H₂₉FN₂O₂

1 reference

Levocabastine (English)

publication date

17 November 2015

canonical SMILES

N#CC1(CCC(CC1)N2CCC(C(C2)C)(C(=O)O)C3=CC=CC=C3)C4=CC=C(C=C4)F

1 reference

levocabastine (English)

3 October 2016

isomeric SMILES

C[C@@H]1CN(CC[C@]1(C(O)=O)C2=CC=CC=C2)[C@H]3CC[C@](CC3)(C#N)C4=CC=C(F)C=C4

1 reference

https://www.whocc.no/atc_ddd_index/?code=R01AC02

14 February 2018

0.6 milligram

route of administration

nasal administration

1 reference

reference URL

World Health Organisation international non-proprietary name

levocabastine (English)

2 references

Levocabastine (English)

medical condition treated

19 January 2016

published in

Recommended INN: List 29

publication date

1989

giant papillary conjunctivitis

1 reference

Australian pregnancy category B3

13 December 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

1 reference

5 March 2018

non-sedating histamine H1 antagonist

1 reference

Medical Subject Headings

15 March 2018

C61806

1 reference

(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid

14 February 2018

0 references

Commons category

Levocabastine

0 references

Identifiers

InChI

InChI=1S/C26H29FN2O2/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20/h2-10,19,23H,11-17H2,1H3,(H,30,31)/t19-,23-,25-,26-/m1/s1

1 reference

levocabastine (English)

3 October 2016

2 references

levocabastine (English)

3 October 2016

14 February 2018

2 references

14 February 2018

https://commonchemistry.cas.org/detail?cas_rn=79516-68-0

10 April 2021

1 reference

Levocabastine (English)

reason for deprecated rank

3 October 2016

PubChem CID

54385

applies to other chemical entity

0 references

ChEBI ID

135679

mapping relation type

exact match

3 references

ChEBI release 2019-10-02

ChEBI release 2021-03-01

International Chemical Identifier

InChI

InChI=1S/C26H29FN2O2/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20/h2-10,19,23H,11-17H2,1H3,(H,30,31)/t19-,23-,25-,26-/m1/s1

1 reference

LEVOCABASTINE (English)

3 October 2016

2 references

inferred from InChIKey

DSSTox substance ID

DTXSID1048548

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

1 reference

Levocabastine (English)

17 November 2015

1 reference

World Health Organisation international non-proprietary name numeric ID

Levocabastine (English)

publication date

17 November 2015

5393

1 reference

reference URL

https://mednet-communities.net/inn/db/ViewINN.aspx?i=5393

1 reference

levocabastine (English)

3 October 2016

1 reference

Medical Subject Headings

14 March 2018

1 reference

14 February 2018

1 reference

UNII

H68BP06S81

2 references

UNII

H68BP06S81

14 February 2018

COU3RRH769

1 reference

1 reference

LEVOCABASTINE (English)

19 January 2016

0 references

1 reference